Hyperphosphatemia in CKD activates macrophages, particularly the pro-inflammatory M1 phenotype, to release cytokines like IL-1β, IL-6, and TNF-α, which promote osteogenic differentiation of VSMCs (51, 52). This evidence concerns the gene IL1B and chronic kidney disease.